• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过分子动力学模拟和结构分析揭示克鲁兹蛋白酶之间的常见模式和差异

Unraveling Common Patterns and Differences among Cruzipains through Molecular Dynamics Simulations and Structural Analyses.

作者信息

Santos Lucianna Helene S, Broilo Campos Augusto César, Corrêa Santos Viviane, Fassio Alexandre Victor, Costa Maurício G S, Ferreira Rafaela Salgado

机构信息

Institut Pasteur de Montevideo, Mataojo 2020, Montevideo 11400, Uruguay.

Departamento de Bioquímica e Imunologia, Universidade Federal de Minas Gerais, Avenida Antônio Carlos 6627, Belo Horizonte 31270-901, Minas Gerais, Brazil.

出版信息

ACS Omega. 2025 May 2;10(18):19115-19128. doi: 10.1021/acsomega.5c01876. eCollection 2025 May 13.

DOI:10.1021/acsomega.5c01876
PMID:40385193
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12079592/
Abstract

Chagas disease (CD) is a neglected tropical disease for which novel and improved treatments are needed. The cysteine protease Cruzipain is one of the main targets for the development of novel drugs for the treatment of CD. Recent bioinformatics analyses have revealed four Cruzipain subtypes whose active sites differ in key positions for ligand recognition. These analyses suggest a possible effect on the substrate specificity and affinity for ligands. To better investigate the impact of substitutions in Cruzipain subtypes, we employed molecular dynamics simulations and varied structural analyses on representatives of each Cruzipain subtype. Our results indicated that the substitutions did not significantly affect the overall flexibility and conformation of these proteases. In contrast, we observed differences in their active site characteristics, including different electrostatic potentials, cavity volumes, and patterns of interactions with the virtual probes. The distinct alterations in the active site subsites, especially in the S2 subsite, suggest unique functional changes that could affect substrate binding, ligand recognition, and possibly enzymatic effectiveness in various biological situations.

摘要

恰加斯病(CD)是一种被忽视的热带疾病,需要新颖且改良的治疗方法。半胱氨酸蛋白酶克氏锥虫蛋白酶是开发治疗CD新药的主要靶点之一。最近的生物信息学分析揭示了四种克氏锥虫蛋白酶亚型,其活性位点在配体识别的关键位置上有所不同。这些分析表明对底物特异性和配体亲和力可能有影响。为了更好地研究克氏锥虫蛋白酶亚型中取代的影响,我们对每种克氏锥虫蛋白酶亚型的代表进行了分子动力学模拟和各种结构分析。我们的结果表明,这些取代并未显著影响这些蛋白酶的整体灵活性和构象。相反,我们观察到它们活性位点特征的差异,包括不同的静电势、腔体积以及与虚拟探针的相互作用模式。活性位点亚位点的明显改变,特别是在S2亚位点,表明可能存在独特的功能变化,这可能会影响底物结合、配体识别,并可能在各种生物学情况下影响酶的有效性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9129/12079592/c9271e7da742/ao5c01876_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9129/12079592/e020b283c36c/ao5c01876_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9129/12079592/3cb853cdf0dc/ao5c01876_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9129/12079592/b39b67a74101/ao5c01876_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9129/12079592/193208253ca4/ao5c01876_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9129/12079592/4520856f2d8a/ao5c01876_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9129/12079592/d7a782c1f6f2/ao5c01876_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9129/12079592/c9271e7da742/ao5c01876_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9129/12079592/e020b283c36c/ao5c01876_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9129/12079592/3cb853cdf0dc/ao5c01876_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9129/12079592/b39b67a74101/ao5c01876_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9129/12079592/193208253ca4/ao5c01876_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9129/12079592/4520856f2d8a/ao5c01876_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9129/12079592/d7a782c1f6f2/ao5c01876_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9129/12079592/c9271e7da742/ao5c01876_0007.jpg

相似文献

1
Unraveling Common Patterns and Differences among Cruzipains through Molecular Dynamics Simulations and Structural Analyses.通过分子动力学模拟和结构分析揭示克鲁兹蛋白酶之间的常见模式和差异
ACS Omega. 2025 May 2;10(18):19115-19128. doi: 10.1021/acsomega.5c01876. eCollection 2025 May 13.
2
The gene repertoire of the main cysteine protease of Trypanosoma cruzi, cruzipain, reveals four sub-types with distinct active sites.克氏锥虫主要半胱氨酸蛋白酶(cruzipain)的基因库揭示了具有不同活性位点的四个亚型。
Sci Rep. 2021 Sep 14;11(1):18231. doi: 10.1038/s41598-021-97490-2.
3
The substrate specificity of cruzipain 2, a cysteine protease isoform from Trypanosoma cruzi.克氏锥虫半胱氨酸蛋白酶同工型克鲁兹蛋白酶2的底物特异性。
FEMS Microbiol Lett. 2006 Jun;259(2):215-20. doi: 10.1111/j.1574-6968.2006.00267.x.
4
Substrate Specificity of Cysteine Proteases Beyond the S Pocket: Mutagenesis and Molecular Dynamics Investigation of Cathepsins L.半胱氨酸蛋白酶S口袋之外的底物特异性:组织蛋白酶L的诱变和分子动力学研究
Front Mol Biosci. 2018 Apr 19;5:40. doi: 10.3389/fmolb.2018.00040. eCollection 2018.
5
Cysteine protease isoforms from Trypanosoma cruzi, cruzipain 2 and cruzain, present different substrate preference and susceptibility to inhibitors.来自克氏锥虫的半胱氨酸蛋白酶同工型,即克氏锥虫蛋白酶2和克氏锥虫蛋白酶,对底物具有不同的偏好性,并且对抑制剂的敏感性也不同。
Mol Biochem Parasitol. 2001 Apr 25;114(1):41-52. doi: 10.1016/s0166-6851(01)00236-5.
6
Interdependence of Inhibitor Recognition in HIV-1 Protease.HIV-1蛋白酶中抑制剂识别的相互依赖性
J Chem Theory Comput. 2017 May 9;13(5):2300-2309. doi: 10.1021/acs.jctc.6b01262. Epub 2017 Apr 11.
7
Human T cell responses against the major cysteine proteinase (cruzipain) of Trypanosoma cruzi: role of the multifunctional alpha 2-macroglobulin receptor in antigen presentation by monocytes.人类针对克氏锥虫主要半胱氨酸蛋白酶(克氏锥虫蛋白酶)的T细胞反应:多功能α2-巨球蛋白受体在单核细胞抗原呈递中的作用。
Int Immunol. 1997 Jun;9(6):825-34. doi: 10.1093/intimm/9.6.825.
8
Comparison of the specificity, stability and individual rate constants with respective activation parameters for the peptidase activity of cruzipain and its recombinant form, cruzain, from Trypanosoma cruzi.克氏锥虫的克氏锥虫蛋白酶及其重组形式克鲁萨因的肽酶活性的特异性、稳定性和各个速率常数与相应活化参数的比较。
Eur J Biochem. 2001 Dec;268(24):6578-86. doi: 10.1046/j.0014-2956.2001.02612.x.
9
Identification of natural lead molecules as potential cruzipain inhibitors and decoding the interaction mechanism for the treatment of Chagas disease: a computational biology analysis.鉴定天然先导分子作为潜在的克氏锥虫蛋白酶抑制剂并解析其治疗恰加斯病的相互作用机制:一项计算生物学分析
Nat Prod Res. 2024 Oct;38(20):3676-3680. doi: 10.1080/14786419.2023.2256018. Epub 2023 Sep 7.
10
Integrated Computational Approaches for Drug Design Targeting Cruzipain.靶向 cruzipain 的药物设计的综合计算方法。
Int J Mol Sci. 2024 Mar 27;25(7):3747. doi: 10.3390/ijms25073747.

本文引用的文献

1
Structure-Aided Computational Design of Triazole-Based Targeted Covalent Inhibitors of Cruzipain.基于结构的克氏锥虫半胱氨酸蛋白酶靶向共价抑制剂的三唑类化合物的计算设计。
Molecules. 2024 Sep 5;29(17):4224. doi: 10.3390/molecules29174224.
2
New drug discovery strategies for the treatment of benznidazole-resistance in , the causative agent of Chagas disease.治疗恰加斯病病原体克氏锥虫贝氏赞德唑耐药的新药发现策略。
Expert Opin Drug Discov. 2024 Jun;19(6):741-753. doi: 10.1080/17460441.2024.2349155. Epub 2024 May 7.
3
Discovery of Novel Inhibitors of Cruzain Cysteine Protease of .
新型克氏锥虫半胱氨酸蛋白酶抑制剂的发现
Curr Med Chem. 2024;31(16):2285-2308. doi: 10.2174/0109298673254864230921090519.
4
UCSF ChimeraX: Tools for structure building and analysis.UCSF ChimeraX:结构构建和分析工具。
Protein Sci. 2023 Nov;32(11):e4792. doi: 10.1002/pro.4792.
5
Molecular targets for Chagas disease: validation, challenges and lead compounds for widely exploited targets.克氏锥虫病的分子靶点:广泛开发靶点的验证、挑战和先导化合物。
Expert Opin Ther Targets. 2023 Jul-Dec;27(10):911-925. doi: 10.1080/14728222.2023.2264512. Epub 2023 Oct 30.
6
Structure-based discovery of novel cruzain inhibitors with distinct trypanocidal activity profiles.基于结构的新型克氏锥虫抑制剂的发现及其独特的杀锥虫活性特征。
Eur J Med Chem. 2023 Sep 5;257:115498. doi: 10.1016/j.ejmech.2023.115498. Epub 2023 May 18.
7
Design, synthesis and biological evaluation of novel thiosemicarbazones as cruzipain inhibitors.新型硫代缩氨基脲类克氏锥虫蛋白酶抑制剂的设计、合成与生物评价。
Eur J Med Chem. 2023 Jun 5;254:115345. doi: 10.1016/j.ejmech.2023.115345. Epub 2023 Apr 7.
8
Screening the Pathogen Box to Discover and Characterize New Cruzain and CatL Inhibitors.筛选病原体文库以发现和鉴定新型克氏锥虫蛋白酶和组织蛋白酶L抑制剂。
Pathogens. 2023 Feb 4;12(2):251. doi: 10.3390/pathogens12020251.
9
Prioritizing Virtual Screening with Interpretable Interaction Fingerprints.基于可解释相互作用指纹的虚拟筛选优先级排序。
J Chem Inf Model. 2022 Sep 26;62(18):4300-4318. doi: 10.1021/acs.jcim.2c00695. Epub 2022 Sep 14.
10
Anti-trypanosomatid drug discovery: progress and challenges.抗利什曼原虫和锥虫药物研发:进展与挑战。
Nat Rev Microbiol. 2023 Jan;21(1):35-50. doi: 10.1038/s41579-022-00777-y. Epub 2022 Aug 22.